Preclinical Research (on Rare Diseases): We Need to Talk About Health Equity

Overview

Journal Mamm Genome

Specialty Genetics

Date 2024 Oct 27

PMID 39461919

Authors

Andy Greenfield

Affiliations

Soon will be listed here.

Abstract

There is a thriving, worldwide, biomedical research community working to understand the molecular bases of diseases of all types, continuously driving improved diagnostics and therapies. Developments in genetics and experimental medicine are yielding novel genetic therapies that were hardly dreamt of 40 years ago. But along with these scientific achievements, there exist challenges in ensuring that 21st century medical interventions are accessible to all who need them. This perspective will discuss how preclinical research, with a focus on rare diseases, can better contribute to healthcare ecosystems that are oriented towards greater health equity. This contribution may require changes to the prevailing scientific research culture that will need support from relevant institutions and the wider community.

References

Avery E, Clark J . Sex-related reporting in randomised controlled trials in medical journals. Lancet. 2016; 388(10062):2839-2840. DOI: 10.1016/S0140-6736(16)32393-5. View

Baynam G, Molster C, Bauskis A, Kowal E, Savarirayan R, Kelaher M . Indigenous Genetics and Rare Diseases: Harmony, Diversity and Equity. Adv Exp Med Biol. 2017; 1031:511-520. DOI: 10.1007/978-3-319-67144-4_27. View

Carrot-Zhang J, Chambwe N, Damrauer J, Knijnenburg T, Robertson A, Yau C . Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer. Cancer Cell. 2020; 37(5):639-654.e6. PMC: 7328015. DOI: 10.1016/j.ccell.2020.04.012. View

Gaviglio A, Skinner M, Lou L, Finkel R, Augustine E, Goldenberg A . Gene-targeted therapies: Towards equitable development, diagnosis, and access. Am J Med Genet C Semin Med Genet. 2023; 193(1):56-63. DOI: 10.1002/ajmg.c.32032. View

Greenfield A . Editing mammalian genomes: ethical considerations. Mamm Genome. 2017; 28(7-8):388-393. DOI: 10.1007/s00335-017-9702-y. View

Halley M, Smith H, Ashley E, Goldenberg A, Tabor H . A call for an integrated approach to improve efficiency, equity and sustainability in rare disease research in the United States. Nat Genet. 2022; 54(3):219-222. PMC: 9016354. DOI: 10.1038/s41588-022-01027-w. View

Halley M, Halverson C, Tabor H, Goldenberg A . Rare Disease, Advocacy and Justice: Intersecting Disparities in Research and Clinical Care. Am J Bioeth. 2023; 23(7):17-26. PMC: 10321139. DOI: 10.1080/15265161.2023.2207500. View

Halmai N, Carvajal-Carmona L . Diversifying preclinical research tools: expanding patient-derived models to address cancer health disparities. Trends Cancer. 2022; 8(4):291-294. PMC: 11586084. DOI: 10.1016/j.trecan.2022.01.007. View

Harlow E, Adair J . Make gene therapies more available by manufacturing them in lower-income nations. Nature. 2024; 631(8021):502-504. DOI: 10.1038/d41586-024-02310-y. View

10.

Koblan L, Erdos M, Wilson C, Cabral W, Levy J, Xiong Z . In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice. Nature. 2021; 589(7843):608-614. PMC: 7872200. DOI: 10.1038/s41586-020-03086-7. View

11.

Liu H, Mei F, Ye R, Han X, Wang S, Ding Y . APOE3ch alleviates Aβ and tau pathology and neurodegeneration in the human APP cerebral organoid model of Alzheimer's disease. Cell Res. 2024; 34(6):451-454. PMC: 11143179. DOI: 10.1038/s41422-024-00957-w. View

12.

Macias-Konstantopoulos W, Collins K, Diaz R, Duber H, Edwards C, Hsu A . Race, Healthcare, and Health Disparities: A Critical Review and Recommendations for Advancing Health Equity. West J Emerg Med. 2023; 24(5):906-918. PMC: 10527840. DOI: 10.5811/westjem.58408. View

13.

Meng X, Yao D, Imaizumi K, Chen X, Kelley K, Reis N . Assembloid CRISPR screens reveal impact of disease genes in human neurodevelopment. Nature. 2023; 622(7982):359-366. PMC: 10567561. DOI: 10.1038/s41586-023-06564-w. View

14.

Nair R, Corrochano S, Gasco S, Tibbit C, Thompson D, Maduro C . Uses for humanised mouse models in precision medicine for neurodegenerative disease. Mamm Genome. 2019; 30(7-8):173-191. PMC: 6759662. DOI: 10.1007/s00335-019-09807-2. View

15.

Wakap S, Lambert D, Olry A, Rodwell C, Gueydan C, Lanneau V . Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2019; 28(2):165-173. PMC: 6974615. DOI: 10.1038/s41431-019-0508-0. View

16.

Patwardhan V, Gil G, Arrieta A, Cagney J, DeGraw E, Herbert M . Differences across the lifespan between females and males in the top 20 causes of disease burden globally: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Public Health. 2024; 9(5):e282-e294. PMC: 11080072. DOI: 10.1016/S2468-2667(24)00053-7. View

17.

Reichart D, Newby G, Wakimoto H, Lun M, Gorham J, Curran J . Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nat Med. 2023; 29(2):412-421. PMC: 9941048. DOI: 10.1038/s41591-022-02190-7. View

18.

Rothstein M, Zimmerer K, Andanda P, Arawi T, Arzuaga F, Chen H . International scope of biomedical research ethics review. Science. 2024; 385(6705):145-147. DOI: 10.1126/science.adp6277. View

19.

Sergouniotis P, Fitzgerald T, Birney E . From genetic variation to precision medicine. Camb Prism Precis Med. 2024; 1:e7. PMC: 10953743. DOI: 10.1017/pcm.2022.11. View

20.

Serrano J, OLeary M, VanNoy G, Mangilog B, Holm I, Fraiman Y . Advancing Understanding of Inequities in Rare Disease Genomics. Clin Ther. 2023; 45(8):745-753. PMC: 10527807. DOI: 10.1016/j.clinthera.2023.06.010. View